Mr. Kieran Donoghue:

I thank Deputy Quinlivan for the question. The IDA portfolio is very varied. We have some very large multinationals, as the Deputy is aware, employing 5,000 or 6,000 people and then we have companies employing 20 or 50 people, so the impact of Brexit will vary across the portfolio. At a high level, we have some engineering firms in the portfolio in regional locations that are very reliant on the UK market so their exposure to Brexit will understandably be higher. While people tend to refer to financial services as an area of opportunity, building on Ms Buckley's observation, an awful of investment funds are sold from Ireland into the UK. They need to preserve access to that UK market post Brexit and if they do not, it could have implications for that sector here. Some life sciences and pharmaceutical firms use the UK as a landbridge and provide intermediate inputs to other firms in the supply chain in the UK on their way to continental Europe. Depending on how Brexit pans out, they could have an exposure they need to manage as well. The essential point is that all of the companies are aware of their exposure and are putting in place approaches to mitigate and manage the risk.